OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Indexing: DOAJ-Directory of Open Access Journals.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.7 weeks (median values) after submission.
Current State of Evaluation and Management of Infectious Conditions in Liver Transplant Candidates and Recipients
Submission Deadline: July 30, 2018 (Open)
Wasim A. Dar, MD, PhD
Assistant Professor of Surgery, Division of Immunology and Organ Transplantation, Department of Surgery, University of Texas at Houston, Health Sciences Center, 6431 Fannin, MSB 6.240, Houston, TX 77030, USA
Tel.: (713) 500-7401 (O); (713) 500-0875 (F)
Website | E-Mail
Research Interests: liver transplantation; kidney transplantation; pancreas transplantation; laparoscopic donor nephrectomy; dialysis access surgery; hepatobiliary surgery; general surgery
About This Topic
Liver transplantation is a critical therapy for the effective management of patients suffering from the complications of end stage liver disease. Outcomes from liver transplantation are vastly improved from the days of its early practice due to increasing technical proficiency during the surgery itself. However this has brought to light other important factors that influence survival including the morbidity and mortality from pre- and post-transplant infectious conditions. Evaluation and management of these infectious conditions therefore will continue to play a larger role in both selecting appropriate transplant candidates and management of patients after receiving a liver transplant. In this special issue of OBM Transplantation we are soliciting scholarly articles devoted to reviewing the current paradigms of care related to such topics as HIV and liver transplantation, the management of Hepatitis B and C pre- and post-transplant, viral reactivation diseases after liver transplantation, and fungal and bacterial diseases and their management affecting liver transplant recipients.
Masayuki Nigo, Rodrigo Hasbun, Karen J Vigil
Received: March 29, 2018; Published: November 2, 2018; doi:10.21926/obm.transplant.1804023
Wasim A. Dar
Received: September 03, 2018; Published: September 29, 2018; doi:10.21926/obm.transplant.1803021
Anita Verma, Katharina Sophia Weigel, Sim You Kuan Dexter, Anil Dhawan
Received: March 26, 2018; Published: May 30, 2018; doi:10.21926/obm.transplant.1802009